DL [China Distance Education] 6-K: China Distance Education Holdings Limited Form 6-K Page
[China Distance Education Holdings Limited Form 6-K Page 3 4 28 33 2 China Distance Education Holdings Limited]
CEO [CNOOC] F-3ASR: (Original Filing)
[] [CNOOC LIMITED Debt Securities Underwriting Agreement Standard Provisions Guarantor Underwriting Agreement Securities Underwriters Representative Issuer Agreement. Trustee From time to time, CNOOC Limited, a company incorporated with limited liability under the laws of Hong Kong (the Registratio]
LFC [CHINA LIFE INSURANCE CO] 6-K: (Original Filing)
[CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock code: 2628) ANNOUNCEMENT ESTIMATED PROFIT INCREASE FOR THE FIRST QUARTER OF 2018 Based on the Companys preliminary estimates, it is estimated that the ne]
OIIM [O2MICRO INTERNATIONAL] 20-F: (Original Filing)
[Large accelerated filer [ ] Accelerated filer [ ] Non-accelerated filer [x] Emerging growth company [ ] † The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012. U.S.]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Sets the Record Straight Regarding False Statements by Shandong Sinobioway Biomedicine Co., Ltd. - Expresses Concern over Aggressive and Damaging Actions Taken by a Minority Shareholder of Sinovac's Beijing Subsidiary – - Reaffirms Commitment to Take All Appropriate Actions to Protect Compan]
SVA [SINOVAC BIOTECH] 6-K: Sinovac Announces Preliminary Results of Phase III Trial
[Sinovac Announces Preliminary Results of Phase III Trial on sIPV BEIJING, April 19, 2018 -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac " or the "Company"), a leading provider of biopharmaceutical products in China, today announced preliminary results of a phase III clinical study on Sabin inactiva]
OIIM [O2MICRO INTERNATIONAL] 20-F: Large accelerated filer [ ] Accelerated filer [
[Large accelerated filer [ ] Accelerated filer [ ] Non-accelerated filer [x] Emerging growth company [ ] † The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012. U.S.]
SVA [SINOVAC BIOTECH] 6-K: Sinovac Sets the Record Straight Regarding False Statements
[Sinovac Sets the Record Straight Regarding False Statements by Shandong Sinobioway Biomedicine Co., Ltd. - Expresses Concern over Aggressive and Damaging Actions Taken by a Minority Shareholder of Sinovac's Beijing Subsidiary – - Reaffirms Commitment to Take All Appropriate Actions to Protect Compan]
ACH [ALUMINUM OF CHINA] 20-F: (Original Filing)
[Title of each class Name of each exchange on which registered American Depositary Shares* Class H Ordinary Shares** _______________________ * Evidenced by American Depositary Receipts. Each American Depositary Share represents 25 H Shares. ** Indicate the number of outstanding shares of each of the ]
MPEL [Melco Resorts & Entertainment] 6-K: (Original Filing)
[Deutsche Bank Trust Company Americas Global Transaction Banking DEPOSITARY RECEIPTS April 19, 2018 Depositarys Notice of General Meeting of Shareholders: ADR/GDR Issue: MELCO RESORTS & ENTERTAINMENT LIMITED CUSIP: 585464100 (DTC Eligible) DR ISIN: US5854641009 Country: Incorporated in the Cayman Is]
